Inhibiting HDAC6 may delay the rapid degradation of misfolded proteins, thereby allowing time for proper folding and partial restoration of function in mutant misfolded PAH proteins offering a novel pathway to enhance the stability of mutant misfolded proteins. The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.